Loma Linda University Eye Institute
Loma Linda University Eye Institute
Loma Linda, California, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency | corneal disorder, eye disorder, limbal stem cell deficiency | Recruiting | Phase 1 | 2026-08-13 | NCT06452316 | |
| A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-07-08 | NCT05287126 | |
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars | Corneal Injuries, Corneal Scar, Craniocerebral Trauma, Eye Injuries, Facial Injuries, corneal disorder, eye disorder, injury, nervous system disorder, nervous system injury | Recruiting | Phase 1 | 2026-04-07 | NCT06257355 | |
| Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, eye disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Not stated | 2026-03-27 | NCT04515524 | |
| Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 | neurotrophic keratopathy | Recruiting | Phase 3 | 2025-12-23 | NCT05555589 |